CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin-proteasome degradation

Biochemical and Biophysical Research Communications

Volumn 386, Issue 3, 2009, Pages 493-498

  Chi, Yayun ^a   Hong, Yi ^a   Zong, Hongliang ^a   Wang, Yanlin ^a   Zou, Weiying ^a   Yang, Junwu ^a   Kong, Xiangfei ^a   Yun, Xiaojing ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CDK11p58; Transcription; Ubiquitination; Vitamin D receptor

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYCLOHEXIMIDE; PROTEASOME; PROTEIN CDK11P58; RNA; UBIQUITIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CYCLIN D3; CYCLINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE METABOLISM; CALCIUM HOMEOSTASIS; CARCINOGENESIS; CELL CYCLE; CELL STRAIN COS1; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; CERCOPITHECUS; GENETIC TRANSFECTION; GENETICS; METABOLISM; TRANSCRIPTION INITIATION; UBIQUITINATION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLINS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, CALCITRIOL; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UBIQUITIN; UBIQUITINATION;

EID: 67650079035     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.061     Document Type: Article

References (29)

1. Pickart C.M. Targeting of substrates to the 26S proteasome. FASEB J. 11 (1997) 1055-1066
2. Haas A.L., and Siepmann T.J. Pathways of ubiquitin conjugation. FASEB J. 11 (1997) 1257-1268
3. Kim T.K., and Maniatis T. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 273 (1996) 1717-1719
4. Murray E.J., Bentley G.V., Grisanti M.S., and Murray S.S. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells. Exp. Cell Res. 242 (1998) 460-469
5. Scheffner M., Huibregtse J.M., Vierstra R.D., and Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 (1993) 495-505
6. Lecker S.H., Goldberg A.L., and Mitch W.E. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J. Am. Soc. Nephrol. 17 (2006) 1807-1819
7. Muratani M., and Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4 (2003) 192-201
8. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., and Jurutka P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13 (1998) 325-349
9. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
10. Vidal M., Ramana C.V., and Dusso A.S. Stat1-vitamin D receptor interactions antagonize 1, 25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription. Mol. Cell Biol. 22 (2002) 2777-2787
11. Carlberg C. Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling. Eur. J. Biochem. 231 (1995) 517-527
12. Aslam F., McCabe L., Frenkel B., van Wijnen A.J., Stein G.S., Lian J.B., and Stein J.L. AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation. Endocrinology 140 (1999) 63-70
13. Morrison N.A., Shine J., Fragonas J.C., Verkest V., McMenemy M.L., and Eisman J.A. 1, 25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246 (1989) 1158-1161
14. Li X.Y., Boudjelal M., Xiao J.H., Peng Z.H., Asuru A., Kang S., Fisher G.J., and Voorhees J.J. 1, 25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol 13 (1999) 1686-1694
15. Masuyama H., and MacDonald P.N. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR. J. Cell. Biochem. 71 (1998) 429-440
16. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., and Evans R.M. Role of CBP/P300 in nuclear receptor signalling. Nature 383 (1996) 99-103
17. Kawasaki H., Eckner R., Yao T.P., Taira K., Chiu R., Livingston D.M., and Yokoyama K.K. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393 (1998) 284-289
18. Baudino T.A., Kraichely D.M., Jefcoat Jr. S.C., Winchester S.K., Partridge N.C., and MacDonald P.N. Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J. Biol. Chem. 273 (1998) 16434-16441
19. Zong H., Chi Y., Wang Y., Yang Y., Zhang L., Chen H., Jiang J., Li Z., Hong Y., Wang H., Yun X., and Gu J. Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. Mol. Cell. Biol. 27 (2007) 7125-7142
20. Cheng C., Kong X., Wang H., Gan H., Hao Y., Zou W., Wu J., Chi Y., Yang J., Hong Y., Chen K., and Gu J. Trihydrophobin 1 interacts with PAK1 and regulates ERK/MAPK activation and cell migration. J. Biol. Chem. (2009)
21. Zong H., Li Z., Liu L., Hong Y., Yun X., Jiang J., Chi Y., Wang H., Shen X., Hu Y., Niu Z., and Gu J. Cyclin-dependent kinase 11(p58) interacts with HBO1 and enhances its histone acetyltransferase activity. FEBS Lett. 579 (2005) 3579-3588
22. Bunnell B.A., Heath L.S., Adams D.E., Lahti J.M., and Kidd V.J. Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. Proc. Natl. Acad. Sci. USA 87 (1990) 7467-7471
23. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am. J. Physiol. Renal. Physiol. 289 (2005) F8-F28
24. Jaaskelainen T., Ryhanen S., and Maenpaa P.H. 9-Cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells. J. Cell. Biochem. 89 (2003) 1164-1176
25. Raval-Pandya M., Dhawan P., Barletta F., and Christakos S. YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein. Mol. Endocrinol. 15 (2001) 1035-1046
26. Sutton A.L., Zhang X., Ellison T.I., and Macdonald P.N. The 1, 25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation. Mol. Endocrinol. 19 (2005) 2234-2244
27. Jaaskelainen T., Ryhanen S., Mahonen A., DeLuca H.F., and Maenpaa P.H. Mechanism of action of superactive vitamin D analogs through regulated receptor degradation. J. Cell. Biochem. 76 (2000) 548-558
28. Ciechanover A., Breitschopf K., Hatoum O.A., and Bengal E. Degradation of MyoD by the ubiquitin pathway: regulation by specific DNA-binding and identification of a novel site for ubiquitination. Mol. Biol. Rep. 26 (1999) 59-64
29. Wang Y., Zong H., Chi Y., Hong Y., Yang Y., Zou W., Yun X., and Gu J. Repression of Estrogen Receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation. J. Biochem. (2009)